UKRI: A £30 million partnership for the development of new dementia treatments
Our partnership with the UK Dementia Research Institute aims to accelerate the development of new diagnostic tests, treatments, and devices for people with dementia.
Partnership overview
- LifeArc has committed £30 million over five years to the UK Dementia Research Institute (UK DRI)
- The funding will accelerate development of new diagnostic tests, treatments, and devices from research discoveries, to identify and treat a range of neurodegenerative diseases that cause dementia
- Around 900,000 people are living with dementia in the UK and this number is projected to rise to 1.6 million by 2040. There is no cure for dementia, and it is a terminal condition
- The partnership brings together the strengths of UK DRI’s research into discovery science with LifeArc’s expertise in translating promising lab discoveries into new tests and treatments for patients
Related information
News Article: £30m partnership with UK Dementia Research Institute
More about our work in Neurodegeneration
Contact us
In submitting your personal data via this form, you consent to being contacted via the details provided so that your enquiry can be responded to. If you would like your data to be removed, please email dataprivacy@lifearc.org.
Please see our Privacy Policy in relation to the personal data you submit to us through this page.
